Financial News · Live Terminal

Page 192 of 722

Inovance Technology 2025 Profit Up 18%; Shares Fall 7%

Shenzhen Inovance Technology (SHE:300124) posted 2025 attributable net profit of 5.05 billion yuan, up 18% from 4.29 billion yuan the previous year.Earnings per share rose to 1.85 yuan from 1.60 yuan, according to a Tuesday filing with the Shenzhen bourse.Revenue climbed 22% year over year to 45.1 billion yuan from 37.0 billion yuan.Shares of the robot maker fell 7% in recent trade.

$SHE:300124

Asia2d ago

Bank of Beijing's Q1 Profit Rises 6%, Revenue Jumps 14%; Shares Drop 4%

Bank of Beijing's (SHA:601169) net profit attributable to shareholders in the first quarter rose 5.6% year on year to 8.10 billion yuan, or 0.38 yuan per share, according to a Shanghai bourse filing on Tuesday.The attributable profit a year earlier was 7.67 billion yuan, or 0.36 yuan per share.Operating revenue jumped 14% to 19.6 million yuan from 17.1 million yuan in the previous year.The Chinese lender's shares dropped 4% during the morning trade Tuesday.

$SHA:601169

Asia2d ago

Huayan Robotics Enters CNC-Cobot Deal With Syntec, Leantec

Guangdong Huayan Robotics (HKG:1021) signed a cooperation memorandum with Syntec Technology (Suzhou) and Suzhou Leantec Automation to jointly develop integrated "CNC + collaborative robots" applications, according to a Monday Hong Kong bourse filing.Shares of the robotics firm were down nearly 3% in Tuesday morning trade.The three parties aim to leverage complementary technologies and market access to promote the adoption of collaborative robots in CNC applications, targeting deployment of more than 10,000 units over 2026-2028.

$HKG:1021

Asia2d ago

Sichuan Biokin Pharma's Q1 Loss Balloons Despite Revenue Growth; Shares Up 3%

Sichuan Biokin Pharmaceutical's (SHA:688506) attributable net loss ballooned to 774.6 million yuan in the first quarter from 531.4 million yuan a year earlier.Loss per share likewise widened to 1.88 yuan from 1.33 yuan, the pharmaceutical company said in a Shanghai bourse filing on Tuesday.Revenue, however, jumped 40% to 94.6 million yuan from 67.4 million yuan, which Biokin attributed to increased market demand for its products.Shares of the company fell nearly 3% in recent trade.

$SHA:688506

Showing 3821-3840 of 14424

Financial News · Live Terminal

Inovance Technology 2025 Profit Up 18%; Shares Fall 7%

Bank of Beijing's Q1 Profit Rises 6%, Revenue Jumps 14%; Shares Drop 4%

Huayan Robotics Enters CNC-Cobot Deal With Syntec, Leantec

Sichuan Biokin Pharma's Q1 Loss Balloons Despite Revenue Growth; Shares Up 3%

Inovance Technology 2025 Profit Up 18%; Shares Fall 7%

Bank of Beijing's Q1 Profit Rises 6%, Revenue Jumps 14%; Shares Drop 4%

Huayan Robotics Enters CNC-Cobot Deal With Syntec, Leantec

Sichuan Biokin Pharma's Q1 Loss Balloons Despite Revenue Growth; Shares Up 3%

Antipa Minerals Says Prefeasibility Study for Western Australia Copper-Gold Project on Track for September Quarter

Montage Technology's Q1 2026 Profit Jumps 61%

Star Entertainment Group Says Fiscal Q3 Revenue Falls 1%; Shares Down 3%

361 Degrees International Eyes HK$618 Million via Top-Up Placement

Research Alert: Shell Agrees To Buy Arc Resources For Usd16.4b

Macquarie Shares Rise After Consortium Agrees To Sell US Electric Utility

Fineos Up After Entering Partnership With Cloud-Based Medical Information Collection Platform

Sungrow Power Supply Q1 Profit Down 40%; Shares Fall 3%

EPS Creative Health Renews Product Purchase Framework With Parent-Linked Supplier

Elsight Says Halo Connectivity Platform Granted US Blue List Status, Shares Up 5%

NZX Midday Sector Update: Electronic Technology Advances, Industrial Services Decline

Dreadnought Resources Completes Reverse Circulation Drilling at Western Australia Project

Pateo Connect Technology to Raise HK$114 Million via Share Subscription

Update: WuXi AppTec's Q1 Profit Up 27%

Alibaba Receives HKEX Nod for Spin Off, Shenzen REIT Listing of Warehouse Park Assets

China Hongqiao Group Eyes 10.2 Billion Yuan in Offshore Debt Offering